PTC Therapeutics | PTCT - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amgen USD 1.94B 237M 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Esperion Therapeutics USD 39.42M 456K 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Novartis USD 3.31B 134M 2025-09
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Xencor USD 17.04M 70.74M 2025-12